RGD

• UNSPSC Description:

  RGD is a tripeptide that effectively triggers cell adhesion, addresses certain cell lines and elicits specific cell responses; binds to integrins.

• Target Antigen:

  Integrin

• Type:

  Peptides

• Related Pathways:

  Cytoskeleton

• Applications:

  Cancer-programmed cell death

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/RGD.html

• Purity:

  98.37

• Solubility:

  DMSO : 1.94 mg/mL (ultrasonic;adjust pH to 3 with HCl)|H2O : 10 mg/mL (ultrasonic)

• Smiles:

  O=C(O)C[C@@H](C(O)=O)NC(CNC([C@H](CCCNC(N)=N)N)=O)=O

• Molecular Weight:

  346.34

• References & Citations:

  [1]Hersel U, et al. RGD modified polymers: biomaterials for stimulated cell adhesion and beyond. Biomaterials. 2003 Nov;24(24):4385-415.Cancer Sci. 2020 May 24;111(8):2803-2813. |Int J Biol Macromol. 2023 Aug 31;126499.|Mater Sci Forum. 2019, 955: 68-73.|Nat Commun. 2024 Apr 18;15(1):3343.|Chem Eng J. 5 February 2022, 135088.|Colloid Polym Sci. 2023 Feb 27.

• Shipping Conditions:

  Blue Ice

• Storage Conditions:

  -80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture and light)

• Clinical Information:

  No Development Reported

• CAS Number:

  99896-85-2